| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |